Drawing for VITRIGEL

USPTO serial 79274679

VITRIGEL

Reviewed by CopyMark Law Group

Reg. 6138690Status 700Renewal
Filing date
Status date
Registration date
Sep 1, 2020
Examiner
POLZER, NATALIE M
Law office
TMEG LAW OFFICE 108

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VITRIGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Industrial chemicals; chemicals, namely, chemical preparations for scientific laboratory use other than for medical or veterinary purposes; cell culture media for scientific, laboratory and research use, other than for medical or veterinary purposes; microorganism cell culture media for laboratory, scientific and research use, other than for medical or veterinary purposes; cell culture media for scientific or research purposes; cell culture media for laboratory useACTIVE—
005Pharmaceutical preparations for the treatment of wounds and cancer; chemical preparations for medical purposes, namely, treating ophthalmological, otolaryngological and dermatological diseases or disorders; chemical preparations for pharmaceutical purposes for eye irritation tests, corneal permeability tests, skin sensitization tests, vascular permeability tests, liver metabolism and excretion tests and intestine absorption tests; collagen for medical purposes; surgical mesh comprised primarily of living tissue; patches comprising living tissues for skin regeneration; patches comprising living tissues for reinforcement of living tissues; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; transplants, namely, implants comprising living tissues; human allograft tissue; drug delivery agents in the form of sheets, threads and hollow fibers that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; microcapsules for delivering drugsACTIVE—
009Laboratory apparatus and instruments for the exchange of substances and heat; measuring or testing machines and instruments, namely, scales, measuring glassware, test tubes; incubators for laboratory use; cell culture apparatus for laboratory use, namely, cell culture dishes; cell culture apparatus for laboratory use, namely, tissue culture flasks; cell culture apparatus for research use, namely, bioreactor for cell culturing; furniture especially made and used for laboratories, namely, chambers for cell culture for laboratory use; bioreactors for cell culture; cell chips being bio-chips for research or scientific purposesACTIVE—
010Medical apparatus and instruments for use in treating ophthalmological, otolaryngological and dermatological diseases and conditions; artificial skin for medical purposes; artificial skin for surgical purposes; prosthetics or fillings materials, namely, artificial materials for use in the replacement of bones, not for dental use; surgical mesh comprised primarily of artificial materials; suture materials; thread for medical purposes; sutures; hollow [ fibers ] * fiber membranes * for medical use; apparatus for drug delivery system, namely, syringes sold filled with living cells; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treatment of dermatological disease; prosthetic tissues for parietal use; prosthetic tissues for visceral use; prosthetic tissues for vascular useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 7, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 5, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 3, 2023NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Nov 28, 2022COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 7, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jan 30, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 18, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 18, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 1, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 13, 2020ALIEASSIGNED TO LIE—
May 8, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 5, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 10, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 3, 2020DOCKASSIGNED TO EXAMINER—
Jan 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance